Close Menu

NEW YORK ─ Life sciences firm LGC said on Thursday that it has acquired infectious-disease antigen and antibody supplier Native Antigen Company (NAC) for an undisclosed amount.

Teddington, UK-based LGC said the deal strengthens its product offering to the IVD sector, which includes a range of quality assurance tools, immunoassay reagents, disease-state plasma, and probes and primers for molecular diagnostic tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.